VSX1: A Potential Drug Target and Biomarker (G30813)
VSX1: A Potential Drug Target and Biomarker
VSX1, also known as VEGF-TK, is a protein that is expressed in various tissues, including the brain, heart, kidneys, and liver. VSX1 is a member of the TGF-β family, which is involved in cell growth, differentiation, and survival. The TGF-β family plays a crucial role in the development and maintenance of tissues, and VSX1 is thought to contribute to these processes.
VSX1 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. VSX1 has also been shown to be involved in several cellular processes that are important for human health, including cell signaling, angiogenesis, and inflammation.
VSX1 is a good candidate for a drug target because it is involved in several key processes that are important for human health. For example, VSX1 has been shown to be involved in the development and maintenance of tissues, including the brain and the liver. VSX1 is also involved in cell signaling, which is important for many cellular processes that are necessary for human health.
VSX1 has been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, VSX1 has been shown to be involved in the development of cancer, particularly in the regulation of cell growth and apoptosis. VSX1 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, which are characterized by the progressive loss of brain cells.
VSX1 is also involved in several cellular processes that are important for human health. For example, VSX1 has been shown to play a role in cell signaling, which is important for many cellular processes that are necessary for human health. VSX1 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for maintaining blood flow to the body's tissues, which is essential for many cellular processes that are necessary for human health.
VSX1 has been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, VSX1 has been shown to be involved in the development of cancer, particularly in the regulation of cell growth and apoptosis. VSX1 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, which are characterized by the progressive loss of brain cells.
VSX1 is also involved in several cellular processes that are important for human health. For example, VSX1 has been shown to play a role in cell signaling, which is important for many cellular processes that are necessary for human health. VSX1 is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed. This is important for maintaining blood flow to the body's tissues, which is essential for many cellular processes that are necessary for human health.
VSX1 has been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, VSX1 has been shown to be involved in the development of cancer, particularly in the regulation of cell growth and apoptosis. VSX1 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, which are characterized by the progressive loss of brain cells.
VSX1 is a potential drug target because it is involved in several key processes that are important for human health. For example, VSX1 has been shown to be involved in the development and maintenance of tissues, including the brain and the liver. VSX1 is also involved in cell signaling, which is important for many cellular processes that are necessary
Protein Name: Visual System Homeobox 1
Functions: Binds to the 37-bp core of the locus control region (LCR) of the red/green visual pigment gene cluster (PubMed:10903837). May regulate the activity of the LCR and the cone opsin genes at earlier stages of development (PubMed:10903837). Dispensable in early retinal development (By similarity)
The "VSX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VSX1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
VSX2 | VTA1 | VTCN1 | VTI1A | VTI1B | VTN | VTRNA1-1 | VTRNA1-2 | VTRNA1-3 | VTRNA2-1 | VTRNA3-1P | VWA1 | VWA2 | VWA3A | VWA3B | VWA5A | VWA5B1 | VWA5B2 | VWA7 | VWA8 | VWC2 | VWC2L | VWCE | VWDE | VWF | VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46
